American Diabetes Association (ADA) The ADA recommends semaglutide as an option for patients with type 2 diabetes who need additional glycemic control after trying lifestyle changes and metformin
Within 24 to 72 hours post ingestion: abdominal pain, nausea, and vomiting are likely to occur
John Whale, 72, has lived with type 2 diabetes for seven years
Safety Considerations for Non-Diabetics Taking Semaglutide Semaglutide is generally well-tolerated in non-diabetic individuals, though gastrointestinal side effects such as nausea, vomiting, and constipation occur in some users during the initial weeks
In clinical trials, adults taking Wegovy, together with eating fewer calories and being more active, achieved an average of 15% weight loss, and about 1 in 3 adults lost 20% of their body weight
Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress